Summit Therapeutics Inc (NASDAQ: SMMT) established initial surge of 4.71% at $23.34, as the Stock market unbolted on Wednesday, before settling in for the price of $22.29 at the close. Taking a more long-term approach, SMMT posted a 52-week range of $15.55-$36.91.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -10.52%. Meanwhile, its Annual Earning per share during the time was -10.52%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -292.63%. This publicly-traded company’s shares outstanding now amounts to $742.81 million, simultaneously with a float of $111.78 million. The organization now has a market capitalization sitting at $17.33 billion. At the time of writing, stock’s 50-day Moving Average stood at $23.40, while the 200-day Moving Average is $22.24.
Summit Therapeutics Inc (SMMT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Summit Therapeutics Inc industry. Summit Therapeutics Inc’s current insider ownership accounts for 84.95%, in contrast to 13.28% institutional ownership. According to the most recent insider trade that took place on Sep 10 ’25, this organization’s Co-Chief Executive Officer bought 333,394 shares at the rate of 17.68, making the entire transaction reach 5,894,406 in total value, affecting insider ownership by 556,088,090. Preceding that transaction, on Sep 11 ’25, Company’s Co-Chief Executive Officer bought 5,000 for 18.07, making the whole transaction’s value amount to 90,350. This particular insider is now the holder of 556,093,090 in total.
Summit Therapeutics Inc (SMMT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
Summit Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -292.63% and is forecasted to reach -0.83 in the upcoming year.
Summit Therapeutics Inc (NASDAQ: SMMT) Trading Performance Indicators
Let’s observe the current performance indicators for Summit Therapeutics Inc (SMMT). It’s Quick Ratio in the last reported quarter now stands at 5.13.
In the same vein, SMMT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.01, a figure that is expected to reach -0.17 in the next quarter, and analysts are predicting that it will be -0.83 at the market close of one year from today.
Technical Analysis of Summit Therapeutics Inc (SMMT)
Now, what If we examine the latest scores posted by [Summit Therapeutics Inc, SMMT]. During the last 5-days, its volume was lower the volume of 3.8 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 93.22% While, its Average True Range was 72.03.
Raw Stochastic average of Summit Therapeutics Inc (SMMT) in the period of the previous 100 days is set at 48.90%, which indicates a major fall in contrast to 95.65% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.04 that was lower than 1.47 volatility it exhibited in the past 100-days period.
